Delivery Order SPE2DB22D2206-SPE2DB24FFX83
- Not listed
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ephedrine Sulfate 50 mg/mL injectable medication, with a total ceiling value of $1,539.62 and a period of performance through March 2025. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,374.55, is for the delivery of Ephedrine Sulfate 50 mg/ml vials. This is a firm fixed-price delivery order contract with a completion date of March 25, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,119.36 Firm Fixed Price Delivery Order is for the supply of 4566136258 - Ephedrine Sulfate 50 mg/mL, with a completion date of October 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award is for the delivery of Ephedrine Sulfate 50 mg/mL Injection to the Defense Logistics Agency (DLA). The contract, valued at $1,418.51, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,499.33 firm fixed-price delivery order is for the supply of Ephedrine Sulfate 50 mg/mL intravenous solution, with a completion date of November 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $10,074.55, is for the delivery of 4,564,060,192 milliliters of Ephedrine Sulfate 50 mg/mL to support military treatment programs and facilities. This delivery order is part of a broader indefinite delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,061.31 firm fixed-price delivery order (SPE2DX15D1053|SPE2DX24F6NTW) is for the supply of 4564899660 Ephedrine Sulfate 50 mg/mL vials. The contract has a completion date of June 14, 2024 and was awarded on June 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,639.79 firm fixed-price delivery order is for the supply of Ephedrine Sulfate 50 mg/ml vials, a medical product used in healthcare settings. The contract has an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,227.05 firm fixed-price delivery order is for the supply of Ephedrine Sulfate 50 mg/ml vials, a key medication used in various medical treatments. The award is issued under a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency awarded a $1,797.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ephedrine Sulfate 50 mg/mL on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside contract was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFX83Delivery Order
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FFX83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Ephedrine Sulfate 50 mg/ml injections, with a total ceiling value of $2,394.97 and a period of performance through March 6, 2024. The contract is structured as a Delivery Order, with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/5/24 |